Pharmaceutical heavyweight GSK on Wednesday said it had settled four lawsuits in the U.S. that claimed its popular heartburn drug Zantac causes cancer, averting a trial due to start in California next month as it and other pharma firms work to manage looming legal threats from the discontinued medication.
